The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000257.3(MYH7):c.4377G>T (p.Lys1459Asn)

CA014901

43012 (ClinVar)

Gene: MYH7
Condition: cardiomyopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: dfd5170f-2105-4cc6-870a-2f7511d716cd
Approved on: 2016-12-15
Published on: 2018-11-16

HGVS expressions

NM_000257.3:c.4377G>T
NM_000257.3(MYH7):c.4377G>T (p.Lys1459Asn)
NC_000014.9:g.23417295C>A
CM000676.2:g.23417295C>A
NC_000014.8:g.23886504C>A
CM000676.1:g.23886504C>A
NC_000014.7:g.22956344C>A
NG_007884.1:g.23367G>T
NR_126491.1:n.735C>A
NM_000257.4:c.4377G>T
ENST00000355349.3:c.4377G>T

Likely Benign

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Conflicting Evidence"
Met criteria codes 2
BS1 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cardiomyopathy VCEP
The filtering allele frequency of the c.4377G>T (p.Lys1459Asn) variant in the MYH7 gene is 0.0375% (34/66566) of European chromosomes by the Exome Aggregation Consortium (http://exac.broadinstitute.org), which is a high enough frequency to be classified as likely benign based on thresholds defined by the ClinGen Inherited Cardiomyopathy Expert Panel (BS1; PMID:29300372). Additionally, while computational prediction tools and conservation analysis suggest that this variant may impact the protein (PP3), this pathogenic evidence code (PP3) was not considered to be in conflict with a likely benign conclusion given the accuracy of computation prediction tools. In summary, this variant meets criteria to be classified as likely benign for cardiomyopathy in an autosomal dominant manner. MYH7-specific ACMG/AMP criteria applied (PMID:29300372): PP3; BS1
Met criteria codes
BS1
Filtering allele frequency of 0.0375% in Europeans in ExAC
PP3
Tools predict damaging
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.